An update on cosmetic procedures in people of color. Part 2: Neuromodulators, soft tissue augmentation, chemexfoliating agents, and laser hair reduction.

Recent years have brought forth the undeniable practice gap in dermatology concerning knowledge and experience of cosmetic procedures in people of color (POC). A paucity in the literature regarding evidence-based recommendations for the management of POC undergoing cosmetic procedures and the rise of cosmetic procedures in dermatology serves as a call to action to provide education regarding differences in skin of color that may impact the cosmetic outcomes. To mitigate the current practice gap on the safety, use, and benefits of cosmetic procedures in POC, part 2 will discuss the authors' recommendations and clinical pearls, as well as evidence-based management for neuromodulators, soft tissue augmentation, chemexfoliating agents, and laser hair reduction in POC undergoing cosmetic procedures.

Informations de copyright

Copyright © 2022 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest Dr Agbai is a speaker for and receives honoraria from AbbVie, is a consultant for and receives honoraria from Unilever, is an author for and receives honoraria from UpToDate, and is an advisory board member and receives honoraria from VisualDx. Dr Burgess serves as a clinical investigator for and receives payments from Allergan, Merz, Revance, and ISDIN. Dr Taylor has the following disclosures: CannTec (Board of Directors), CannTec (Employee – Spouse), AbbVie (Advisory Board), Arcutis, Inc. (Advisory Board, Investigator), Armis Biopharma, Inc. (Consultant), Beiersdorf, Inc. (Speaker/Faculty Education, Consultant), Biorez, Inc. (Advisory Board), Cara Therapeutics (Consultant), Concert Pharmaceuticals (Investigator), Croma-Pharma GmbH Austria (Investigator), Eli Lilly and Company (Investigator), EPI Pharma (Advisory Board), Evolus, Inc. (Speaker/Faculty Education, Advisory Board), Galderma Laboratories, L.P. (Advisory Board), GloGetter, Inc./GloDerm (Advisory Board), Hugel (Advisory Board), Immune Tolerance Network (Investigator), Johnson & Johnson Consumer Products Company (Consultant), Janssen Scientific (Advisory Board/Consultant), LivDerm (Speaker/Faculty Education), L’Oreal USA, Inc. (Speaker/Faculty Education, Advisory Board), MedScape/WebMD (Speaker, Advisory Board), Pfizer, Inc. (Investigator), PictionHealth/Lumin DX (Consultant), Scientis US, Inc. (Advisory Board), UCB (Advisory Board, Consultant), Vichy Laboratoires (Advisory Board), McGraw-Hill (Book Royalties).Sente Labs (Advisory Board – no longer an active relationship), WalgreenBoots (Advisory Board – no longer an active relationship). Dr. Quiñonez has no conflicts of intrest to disclose.